How Long Can Amarantus Bioscience Holdings, Inc. (OTCBB:AMBS) Climb

[[tagnumber 0]][[tagnumber 1]]Amarantus Bioscience Holdings, Inc. (OTCBB:AMBS) has always attracted investor attention as it is one of the companies that constantly issues press releases and letters to shareholders, keeping them well informed about the progress that the company is making.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]After the major crash that happened in the end of July, however, the ticker has been having a hard time keeping its price and managed to drop below the $0.10 per share mark in October, despite the optimism sprouting from the news.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]What might be the reason for this, you may ask. Well, one of the things that can keep [[tagnumber 10]]AMBS[[tagnumber 11]] back is the financial state of the company. Let’s have a recap of the numbers of prime interest contained in the company’s quarterly report for the period ended September 30.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 15]] [[tagnumber 16]]cash: $680 thousand[[tagnumber 17]] [[tagnumber 16]]current assets: $1.1 million[[tagnumber 17]] [[tagnumber 16]]current liabilities: $3.3 million[[tagnumber 17]] [[tagnumber 16]]quarterly revenues: ZERO[[tagnumber 17]] [[tagnumber 16]]quarterly net loss: $4.3 million[[tagnumber 17]] [[tagnumber 26]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]][[tagnumber 10]]AMBS[[tagnumber 11]] certainly has low cash reserves for a biotech company, but it seems that the torrent of news is enough to boost its share price over the past week of trading. Apparently, the company has some good results from the testing of their Mesencephalic–Astrocyte–derived Neurotrophic Factor (MANF), but we are quite sure that there will still be a lot of time before the company begins to generate revenues.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]How will the company finance itself until that time comes. The most probable way to acquire funding to continue its operations is to continue issuing shares. Let’s not forget that in just 9 months [[tagnumber 10]]AMBS[[tagnumber 11]] printed more than 212 million shares, increasing the OS count from 574 million to 786 million.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]This might have a serious impact on the price of the company stock, so be sure to do your due diligence and weigh out the risks before putting any money on the line.[[tagnumber 2]]